Discover 1,605 paid clinical trials in Newnan, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,605
Active & Responsive
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
for
Glioblastoma, IDH-Wildtype
Location: Atlanta GA, Birmingham AL, Jacksonville FL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT06319027
Phase2, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
for
Primary Myelofibrosis (PMF),
Location: Atlanta GA, St. Petersburg FL, Indianapolis IN,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07357727
Phase3, Recruiting
Active & Responsive
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
for
Breast Cancer Triple Negative, Breast Cancer Stage II,
Location: Atlanta GA
Sponsor: Emory University
Sex: Female
Age: 18+
Code: NCT05877859
Recruiting
Active & Responsive
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06492759
Phase2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Location: Atlanta GA, Huntsville AL, Nashville TN,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07284758
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
for
Colorectal Cancer, Colorectal Cancer (CRC),
Location: Atlanta GA, Jacksonville FL, Fairfax VA,
Sponsor: Cartography Biosciences
Sex: All
Age: 18+
Code: NCT07321106
Phase1, Recruiting
Active & Responsive
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
for
Solid Tumors
Location: Atlanta GA, Baltimore MD, New York NY
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07492680
Phase2, Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: Atlanta GA, Jefferson LA, St Louis MO, Fairfax VA,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase1, Recruiting
Active & Responsive
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
for
Breast Neoplasms, Colorectal Neoplasms, Prostate Neoplasm,
Location: Atlanta GA, Tampa FL, St Louis MO, Detroit MI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07114601
Phase1, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Atlanta GA, Knoxville TN, Spartanburg SC,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase3, Recruiting
Active & Responsive
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
for
Bone Pain, Metastatic Malignant Neoplasm in the Bone,
Location: Atlanta GA, Philadelphia PA, New York NY,
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT03858205
Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Atlanta GA, Nashville TN, Jacksonville FL, Lexington KY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Male
Age: 18+
Code: NCT06925737
Phase3, Recruiting
Active & Responsive
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Atlanta GA, Birmingham AL, Nashville TN, Savannah GA,
Sponsor: Massive Bio, Inc.
Sex: All
Age: 0+
Code: NCT03452774
Recruiting
Active & Responsive
A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome
for
Phelan-McDermid Syndrome
Location: Atlanta GA, Birmingham AL, Cincinnati OH, Columbus OH,
Sponsor: Neuren Pharmaceuticals Limited
Sex: All
Age: 3 - 12
Code: NCT07281079
Phase3, Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Atlanta GA, Birmingham AL, Chattanooga TN, Knoxville TN,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase2, Recruiting
Active & Responsive
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
for
Parkinson Disease
Location: Atlanta GA, Birmingham AL, Gainesville FL, Tampa FL,
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sex: All
Age: 30+
Code: NCT04477785
Recruiting
Active & ResponsiveNew
Digital STEADI Efficacy
for
Fall, Mild Cognitive Impairment (MCI), Aging
Location: Atlanta GA
Sponsor: Friendi.fi Corporation
Sex: All
Age: 50+
Code: NCT07852650
Phase1, Phase2, Recruiting
Active & Responsive
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
for
Fabry Disease
Location: Atlanta GA, Birmingham AL, Cincinnati OH, Pittsburgh PA,
Sponsor: UniQure Biopharma B.V.
Sex: Male
Age: 18 - 65
Code: NCT06270316
Phase1, Phase2, Recruiting
Active & Responsive
MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
for
Neisseria Meningitidis
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 25
Code: NCT07197762
Recruiting
Active & Responsive
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study